Medworxx Inc. (“Medworxx”)
(TSXV:MWX),
a leader in clinical patient flow, and compliance and education
solutions, announced today that George Elliott has been appointed as the
new Chairman of the Board of Directors of Medworxx, effective
immediately. Bernard Webber has stepped down from the Chairman position;
he will continue to serve Medworxx as a director.
George Elliott has been a director, executive or advisor to public
companies ranging from large commercial printing, mortgage servicing,
constructions lending and research companies. He had a 35 year career
with Canada’s largest law firms focusing on business development and
relationship management. George is a graduate of the Directors Education
Program at the Rotman School of Management, University of Toronto.
“Medworxx would like to express our sincere thanks to Bernard Webber,
for his guidance and leadership. He has been instrumental in taking us
this far, including through the transition from private to public
company,” said Dan Matlow, President & CEO, Medworxx. “We are also
pleased to welcome George Elliott to the position of Chairman and are
confident that his experience with public companies will help guide our
growth and success.”
“I look forward to focusing on aligning the Medworxx Board of Directors
with the future growth potential of the company,” said George Elliott,
Chairman of the Board. “The company, with its large Canadian footprint,
UK presence, and global expansion plans is well positioned for growth in
the coming years.”
About Medworxx
Medworxx delivers health information
solutions to over 350 hospitals internationally; including Canada,
United States and United Kingdom. Medworxx helps hospitals meet patient
flow challenges, and requirements in compliance and education. Medworxx
Clinical Criteria – flagship of Medworxx Patient Flow that includes
electronic bed board and independent assessment components – currently
serves over 33% of the acute care beds in Canada. Founded in 2004,
Medworxx is based in Toronto, ON, and publicly traded on the TSX Venture
Exchange: MWX.
Visit: www.medworxx.com
The TSX Venture Exchange does not accept responsibility for the adequacy
or accuracy of this release.
Disclaimer
This press release contains forward-looking statements. Often, but
not always, forward-looking statements can be identified by the use of
words such as “plans”, “expects” or “does not expect”, “is expected”,
“estimates”, “intends”, “anticipates” or “does not anticipate”, or
“believes”, or variations of such words and phrases or state that
certain actions, events or results “may”, “could”, “would”, “might” or
“will” be taken, occur or be achieved. Forward-looking statements
involve known and unknown risks, uncertainties and other factors, such
as competition, technological changes, the changing needs of hospitals,
the financial condition of the Company’s current and potential
customers, foreign currency exchange rates, as well as general economic
conditions, which may cause the actual results, performance or
achievements of the Corporation and Medworxx to be materially different
from any future results, performance or achievements expressed or
implied by the forward-looking statements. Actual results and
developments are likely to differ, and may differ materially, from those
expressed or implied by the forward-looking statements contained in this
press release. There can be no assurance that forward-looking statements
will prove to be accurate, as actual results and future events could
differ materially from those anticipated in such statements.
Accordingly, readers should not place undue reliance on forward-looking
statements.
Copyright Business Wire 2013